These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 1491225)

  • 1. The osteoclast proton pump differs in its pharmacology and catalytic subunits from other vacuolar H(+)-ATPases.
    Chatterjee D; Chakraborty M; Leit M; Neff L; Jamsa-Kellokumpu S; Fuchs R; Bartkiewicz M; Hernando N; Baron R
    J Exp Biol; 1992 Nov; 172():193-204. PubMed ID: 1491225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity to vanadate and isoforms of subunits A and B distinguish the osteoclast proton pump from other vacuolar H+ ATPases.
    Chatterjee D; Chakraborty M; Leit M; Neff L; Jamsa-Kellokumpu S; Fuchs R; Baron R
    Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6257-61. PubMed ID: 1385872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitivity to nitrate and other oxyanions further distinguishes the vanadate-sensitive osteoclast proton pump from other vacuolar H(+)-ATPases.
    Chatterjee D; Neff L; Chakraborty M; Fabricant C; Baron R
    Biochemistry; 1993 Mar; 32(11):2808-12. PubMed ID: 8457547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [3H]Bafilomycin as a probe for the transmembrane proton channel of the osteoclast vacuolar H(+)-ATPase.
    Mattsson JP; Keeling DJ
    Biochim Biophys Acta; 1996 Apr; 1280(1):98-106. PubMed ID: 8634321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subunit G of the vacuolar proton pump. Molecular characterization and functional expression.
    Crider BP; Andersen P; White AE; Zhou Z; Li X; Mattsson JP; Lundberg L; Keeling DJ; Xie XS; Stone DK; Peng SB
    J Biol Chem; 1997 Apr; 272(16):10721-8. PubMed ID: 9099722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and cellular distribution of the osteoclast ruffled membrane vacuolar H+-ATPase B-subunit using isoform-specific antibodies.
    Mattsson JP; Skyman C; Palokangas H; Väänänen KH; Keeling DJ
    J Bone Miner Res; 1997 May; 12(5):753-60. PubMed ID: 9144341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine ameloblasts are immunonegative for Tcirg1, the v-H-ATPase subunit essential for the osteoclast plasma proton pump.
    Bronckers AL; Lyaruu DM; Bervoets TJ; Medina JF; DenBesten P; Richter J; Everts V
    Bone; 2012 Apr; 50(4):901-8. PubMed ID: 22245629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and reconstitution of a vacuolar-type proton pump of osteoclast membranes.
    Mattsson JP; Schlesinger PH; Keeling DJ; Teitelbaum SL; Stone DK; Xie XS
    J Biol Chem; 1994 Oct; 269(40):24979-82. PubMed ID: 7929181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The bisphosphonate tiludronate is a potent inhibitor of the osteoclast vacuolar H(+)-ATPase.
    David P; Nguyen H; Barbier A; Baron R
    J Bone Miner Res; 1996 Oct; 11(10):1498-507. PubMed ID: 8889850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vacuolar and plasma membrane proton-adenosinetriphosphatases.
    Nelson N; Harvey WR
    Physiol Rev; 1999 Apr; 79(2):361-85. PubMed ID: 10221984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the osteoclast vacuolar H(+)-ATPase B-subunit.
    Bartkiewicz M; Hernando N; Reddy SV; Roodman GD; Baron R
    Gene; 1995 Jul; 160(2):157-64. PubMed ID: 7642089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and function of V-ATPases in osteoclasts: potential therapeutic targets for the treatment of osteolysis.
    Xu J; Cheng T; Feng HT; Pavlos NJ; Zheng MH
    Histol Histopathol; 2007 Apr; 22(4):443-54. PubMed ID: 17290355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of proton transport in bone-derived membrane vesicles.
    Mattsson JP; Lorentzon P; Wallmark B; Keeling DJ
    Biochim Biophys Acta; 1993 Feb; 1146(1):106-12. PubMed ID: 8443216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diversity of proton pumps in osteoclasts: V-ATPase with a3 and d2 isoforms is a major form in osteoclasts.
    Matsumoto N; Daido S; Sun-Wada GH; Wada Y; Futai M; Nakanishi-Matsui M
    Biochim Biophys Acta; 2014 Jun; 1837(6):744-9. PubMed ID: 24561225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omeprazole and bafilomycin, two proton pump inhibitors: differentiation of their effects on gastric, kidney and bone H(+)-translocating ATPases.
    Mattsson JP; Väänänen K; Wallmark B; Lorentzon P
    Biochim Biophys Acta; 1991 Jun; 1065(2):261-8. PubMed ID: 1647821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of vacuolar-ATPase and selective inhibition of vacuolar-H(+)-ATPase in osteoclasts.
    Yao G; Feng H; Cai Y; Qi W; Kong K
    Biochem Biophys Res Commun; 2007 Jun; 357(4):821-7. PubMed ID: 17462591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pharmacological assessment of the mammalian osteoclast vacuolar H(+)-ATPase.
    Hall TJ; Schaueblin M
    Bone Miner; 1994 Nov; 27(2):159-66. PubMed ID: 7711523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocytochemical localization of vacuolar H+-ATPase and Cl--HCO3- anion exchanger (erythrocyte band-3 protein) in avian osteoclasts: effect of calcium-deficient diet on polar expression of the H+-ATPase pump.
    Bastani B; Ross FP; Kopito RR; Gluck SL
    Calcif Tissue Int; 1996 May; 58(5):332-6. PubMed ID: 8661962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of osteoclast bone resorption by disrupting vacuolar H+-ATPase a3-B2 subunit interaction.
    Kartner N; Yao Y; Li K; Crasto GJ; Datti A; Manolson MF
    J Biol Chem; 2010 Nov; 285(48):37476-90. PubMed ID: 20837476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Animal plasma membrane energization by chemiosmotic H+ V-ATPases.
    Harvey WR; Wieczorek H
    J Exp Biol; 1997 Jan; 200(Pt 2):203-16. PubMed ID: 9050228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.